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News
Solutia reviewing options for phosphorus deriva-
tives business
St. Louis, 1 July 1998: Solutia (NYSE:SOI) said today
that it is reviewing options for its phosphorus derivatives
business, including sale, alliance and joint venture, and
has retained the investment banking firm Goldman Sachs
to assist in the evaluation.
"The phosphorus derivatives business has been profitable
for Solutia," said Michael E. Miller, Solutia vice chair-
man, "but it’s clear that global consolidation in some
form in this industry is likely to happen. To fulfill
management’s commitment to the Board of Directors
and to our stockholders, it’s imperative that we explore
value-enhancing opportunities for our businesses".
News from the September issue of Performance
chemicals international
Surfactants: It is a time ofchange in the surfactants sector.
Increasingly, demanding customer requirements in both
the industrial and personal care areas, as well as the
growing importance ofenvironmental considerations, are
encouraging change right across the sector. Mirroring the
trend in the rest of the industry, M&A activity has been
intense over the past year or so as we move towards fewer
but larger players. The sector is consolidating in an
attempt to improve its profitability, a phenomenon seen
throughout the speciality sector which is making life
harder for the smaller player.
Food additives: The market for food additives is character-
ized by increasing sophistication with demand mainly
propelled by the rapidly growing processed foods sector.
As lifestyles change and food processing technology
evolves, there is increasing demand for a variety of food
additives, ranging from sweeteners to thickeners. ’Con-
sumer preference in foods and flavours is continually
changing due to fashion, lifestyle changes and the focus
on healthy eating,’ says Manoj Gujral, business director
and general manager at Oxford Chemicals, a company
that specializes in the manufacture and supply of speci-
ality aroma chemicals to the global market for flavours
and fragrances.
Ireland: Ireland is becoming a key location for the
European pharmaceutical and chemical industry. More
than 120 overseas companies employ 15 000 people in this
sector in Ireland. In 1997, pharmaceutical products
worth more than $7bn were exported. This represents
15% of total exports and makes Ireland one of the
world’s largest exporters of pharmaceuticals and fine
chemicals--sectors that dominate the Irish chemical
industry. The heavy and petrochemical industry is not
well represented due to a lack of raw materials and the
capital-intensive nature of this end of the industry.
Catalysts: Catalysts remain one of the more innovative
areas ofchemistry with new technologies being developed
that could have dramatic impacts on he economics of
chemical processes worldwide. In the USA, a researcher
has suggested a method of using combinatorial chemistry
to discover new solid-state catalysts. In a paper published
in the latest edition of Nature magazine, Selim Sankan of
the chemical engineering department at the University of
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California, Los Angeles, suggests a ’mass screening’ tech-
nique that could speed up the current trial and error
process. The pharamaceutical industry already uses
combinatorial synthesis methods, in combination with
mass-screening techniques, to speed up the discovery of
new drugs.
Technical alert: A US consortium has announced what it
describes as a ’a major milestone’ in the development of
biotechnological routes to chemicals from renewable
resources. The consortium members are Genencor Inter-
national, Eastman Chemical, Electrosynthesis Company,
MicroGenomics and Argonne National Laboratory, a
Department of Energy (DOE) lab. The first target
chemical for the process is ascorbic acid, which has a
world market worth $600m. The consortium says the
process could cut the capital cost by halfcompared to the
conventional Reichstein process.
For more information, call the Editor Alan Tyler at 44-
181-652 8126, email alantyler@rbi.co.uk.
Performance Chemicals International is published by the
Reed Chemical Group, part ofReed Business Informa-
tion (RBI). The Reed Chemical Group also includes
Asia-Pacific Chemicals, Asian Chemical News, European
Chemical News, Chemical Insight and 24 h online service
Chemical News and Intelligence (CNI).
RBI publishes over 60 titles including: New Scientist,
Flight International, Estates Gazette, Contract dTournal,
Commercial Motor, Doctor, Bankers Almanac, Kelly’s Busi-
ness Directory, Kompass British Exports and many more.
For a full listing see RBI’s web site http://www.reed-
business.com
tions. It shows which companies performed well in 1997
and points to future strengths.
The analysis issue contains detailed financial information
on the top 30 companies in the chemical industry. It
ranks companies by sales and gives net profits and net
margins, and research and development and capital
spending figures. Productivity is an important element
of the analysis, and the productivity data published rank
companies by sales per employee and give figures for
value added, employee numbers and employee costs.
The industry is facing difficult times now, and Union
Carbide is not alone is issuing a third quarter 1998 profits
warning. However, average industry sales rose by 7% last
year. Cash flows were 9% higher and pre-tax profits up
by 12%.
Chemical Insight is published by Reed Chemical Publications
in the UK, Reed Business Information (RBI), a division ofReed
Elsevier. Other chemical publications published by RBI include
European Chemical News, Asia Pacific Chemicals, Per-
formance Chemicals International, and Chemical News &
Intelligence, a worldwide, Internet-based 24h news service.
Reed Business Information also publishes over 60 titles’, in-
cluding: Flight International, Estates Gazette, Contract
Journal, Commercial Motor, Doctor, Bankers Almanac,
Kelly’s Business Directory, Kompass British Exports, and
many more. For a full listing see RBI’s web site--http:
//www.reedbusiness.com. For further details about Chemical
Insight, contact the Editor, Nigel Davis, e-mail: nigel.davis@
rbi.co.uk, Tel: + 44 (0) 181 652 3397, Fax: + 44 (0) 181 652
8952
Top five chemical companies generated $134.6 bn
in sales in 1997, new analysis shows
The five largest chemical companies in the world gener-
ated sales of $134.6 billion in 1997 and profits before tax
totalling $15.5 billion, according to Chemical Insight’s
analysis of annual financial performance in the chemical
industry. Combined net profits for the top five were $7.7
billion.
The 1997 analysis puts four US companies at the head of
the performance league table--Union Carbide, Georgia
Gulf, Rohm & Haas, and Nalco. These are followed by
one of Europe’s largest petrochemical producers, Borea-
lis, and Britain’s pharmaceuticals, agrochemicals and
speciality chemicals producer, Zeneca. The chemical
industry is heading for hard times, but the analysis for
1997 shows just how much stronger some of the European
producers have become and their good standing--in
1997 at least--among their peers.
This critical comparison looks at the performance of
companies across the globe. It assesses performance
according to 32 financial measures and ratios, and looks
at the industry in ways which compare year-on-year
performance, profitability, productivity and financial
health. The analysis is all about comparisons across
national boundaries, regions and accounting conven-
Patent application fees abolished
Small firms and private individuals benefitted most when
the United Kingdom Patent Office abolished the applica-
tion fee for patents from October 1998. The Office is the
first in the industrialized world not to charge a patent
application fee.
Abolition of the filing fee forms part of a 20% cut in
Patent Office fees that came into effect on October.
Other reductions include a cut in the trademark applica-
tion fee from 225 to 200, a cut in trademark registra-
tion renewal from 250 to 200, and cuts in patent
renewal fees by an average of 18%.
The cuts assist entry into the systems of patents, trade-
marks and registered designs, and encourage their use by
small firms and private individuals. The greatest savings
to be made are in patent renewals in the earlier years,
when companies are frequently still in the phase of
product development and have yet to make a return on
their investment. Savings to industry will equal 12
million, or 20% of the Patent Office’s fee income.
Welcoming the fee reductions, Patent Office chief execu-
tive Paul Hartnack said: ’The reductions in Patent Office
fees make a significant contribution to the competitive-
ness of British industry, particularly among the small
firms which are the source ofinnovation and creativity in
Britain’.
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’The fee reductions have been made possible by the
continuous and successful efforts of management and
staff to raise the quality of service and reduce unit costs
since the Patent Office relocated to Newport, South
Wales, in 1991’.
Details of the fee reductions are available on the Patent
Office Web site at www.patent.gov.uk/snews/notices/red-
fee.html. Copies of the statutory instruments are avail-
able fi’om the Stationery Office Bookshops and from the
Patent Office. They are The Trade Marks (Fees) Rules 1998
(SI 1998 No 1776), 1.10; The Registered Designs (Fees)
Rules 1998 (SI 1998 No 1777), 1.10 and The Patents
(Fees) Rules 1998 (SI 1998 No 1778), 1.95).
For information, contact Brian Caswell, The Patent Offce,
+44 (0)1633 814729 or Michael Binns, Prowse & Co,
+ 44 (0)1372 363386.
21st century requirements to monitor our envir-
onment prompts action by The Royal Society of
Chemistry
Modern instrumentation has allowed us to push back the
fi’ontiers of detection such that we are able to determine
incredibly small anaounts of natural and anthropogenic
pollutants and contaminants in our environment,
whether they are in our homes, workplaces, cities, the
countryside or the oceans. The fact that we can detect
these pollutants in minuscule amounts does not necess-
arily mean that the levels present in the environment are
harmful to our health or well being, but it does drive
world-wide legislation on these substances. Theretbre,
there is a requirement to monitor, ascertain the sources,
prevent the release, develop better detection methods and
make properly assessed scientific judgements on the
toxicity, exposure and risk assessment of the pollutants
to which we are exposed in our daily lives.
The Royal Society of Chemistry has recognized the
importance of these 21st century requirements, and that
it is essential to promote and disseminate the knowledge
of newly developed technologies for monitoring our vari-
ous environments. Therefore, it is launching the Journal of
Environmental Monitoring (JEM) which is dedicated to
assessing exposure and health risks through the latest
developments in measurement science. The journal, with
the first issue due to be published in February 1999 and
then bi-monthly thereafter, is unique in that it aims to
publish all the relevant information on this subject area
in one source.
This journal is intended for environmental and health
professionals in industry, and officials ii’om governmental
and regulatory agencies as well as research scientists
interested in the environment.
"I think the journal will be of interest to all analytical
scientists involved with environmental monitoring issues.
Currently at NIOSH, environmental monitoring is one of
the key components of the National Occupational Re-
search Agenda (NORA)". Dr E. R. Kennedy, NIOSH,
Cincinnati, USA.
"Environmental contaminants are becoming the No.
public concern". Mr J. V. Dutton, Consultant, UK.
"The launching of a journal dedicated to environmental
monitoring with some emphasis on legislative issues is an
excellent idea". Dr. Philippe Quevauviller, European
Commission, DGXII SM&T Programme, Belgium.
The Royal Society of Chemistry (RSC) is a learned
society with a worldwide membership of 46000. it has
as its main objectives the advancement of the science of
chemistry and its applications, and the maintenance of
high standards of competence and integrity among
practising chemists. The RSC markets a comprehensive
range of high quality information products and services.
For further details contact: Harpal Minhas, The Royal
Society of Chemistry, Thomas Graham House, Science
Park, Milton Road, Cambridge CN4 4WF, UK. Tel"
+ 44 (0) 1223 432292; Fax: + 44 (0) 1223 420247; e-mail:
jem@rsc.org; URL: www.rsc.org/jem
Meetings reports
Micromass host international seminar on the
enabling role of MS
Micromass, the mass spectrometry people, hosted MS in
Proteomics & Drug Discovery: An International Seminar on the
Enabling Role ofMS. The seminar, which was open to the
public and incorporated Micromass’ 1998 organic MS
users’ meeting, the first event of its kind to be organized
by the company since its re-formation in 1996.
The seminar saw a move from central Manchester, the
traditional home of the Micromass user meeting, to
Shrigley Hall in Cheshire. From 18th to 20th October
1998, this impressive 19th century country mansion
housed an international panel of invited speakers and
Micromass users, presenting an insight into emerging
MS-based strategies in proteomics and contemporary
drug discovery]development. Speakers included Roland
Annan (SmithKline Beecham, PA, USA), Walter Black-
stock (Glaxo Wellcome, UK), Daryl Pappin (Imperial
Cancer Research Foundation, UK) and Jeffrey Kiplin-
get (Pfizer, Groton, CT, USA).
Originally planned as a ’stand-alone’ meeting to be
hosted, earlier in 1998, by Glaxo-Wellcome, the proteo-
mics sessions were, through unexpectedly popular de-
mand, rescheduled at this larger venue. Protein
identification using MS and bio-informatics is becoming
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